IRIDEX Corp. (IRIX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about IRIDEX Corp. (IRIX)
Go deeper and ask any question about IRIX
Company Performance
Current Price
as of Sep 13, 2024$2.01
P/E Ratio
N/A
Market Cap
$33.44M
Description
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.
Metrics
Overview
- HQMountain View, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerIRIX
- Price$2.01-0.50%
Trading Information
- Market Cap$33.44M
- Float74.54%
- Average Daily Volume (1m)18,087
- Average Daily Volume (3m)24,646
- EPS-$0.67
Company
- Revenue$49.70M
- Rev Growth (1yr)-1.74%
- Net Income-$2.68M
- Gross Margin40.00%
- EBITDA Margin-17.96%
- EBITDA-$2.27M
- EV$33.36M
- EV/Revenue0.67
- P/EN/A
- P/S0.66
Documents
SEC Filings
Earnings Calls
Factset Street Account